Our editorial promise
Good science is rarely a slogan. We make the question, evidence, limits, and commercial context easy to see.
New to the science?
Six short reads. One strong foundation. No scientific background required.
Explore by subject
GLP-1, GIP, amylin, glucose regulation, and body composition.
Receptors, agonists, half-life, trials, and evidence quality.
COAs, identity, purity, methods, and batch traceability.
Tendon, ligament, recovery, wound healing, and veterinary research.
Rules, prohibited substances, and strict-liability risk.
Structured, neutral research profiles organized by evidence.
Featured field guide
Start with the hormone. Learn the receptor. Then place agonists, evidence, glucose regulation, appetite, and body composition in context.
Visual guides
Two saveable explainers for understanding incretin pathways and keeping weight-loss plateaus in perspective.
A pathway overview—not a head-to-head safety or effectiveness comparison. Effects vary by compound and population. Retatrutide and cagrilintide remain investigational and are not FDA-approved.
View with context
A general educational checklist, not an instruction to change a prescription. Do not increase, decrease, start, or stop a medicine based on this graphic; review the product-specific plan with the prescribing clinician.
View with contextPONY Library
Each page answers one question clearly, identifies the kind of evidence behind it, and points to the next useful idea.
Equine research
An emerging library on tendon, ligament, wound healing, recovery, study design, and the limits of cross-species interpretation.
Recently reviewed
A research-based review of BPC-157 and TB-500 in horses, including equine safety data, tendon and ligament cases, wound-healing cases, and the limits of current evidence.
What does the science say about BPC-157 and TB-500 for horse tendon and suspensory injuries? A clear review of equine cases and the underlying research.
Two equine wound cases have reported improvement during BPC-157/TB-500 therapy. Here’s what happened, what the research supports, and what remains unknown.
The evidence standard
Every claim passes through the same questions: What kind of study? How many subjects? Compared with what? For how long? Who funded it? What does it leave unresolved?
How we evaluate evidenceRecommended research partner
Included for its approach to testing documentation, batch information, and research education. Commercial relationship disclosed; editorial conclusions remain independent.